The previous research demonstrated that COVID-19 can enter pancreatic islet cells through angiotensin-converting enzyme-2 (ACE-2) receptors and cause reversible β-cell damage and transient hyperglycemia through this mechanism, the possibilities for potential new-onset diabetes triggered by COVID-19 have increased [5]. The gene discussed is ACE2; the disease is COVID-19.